Atalaya Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Atalaya Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-125,000	Closed	-$7.5K	–	148
2023 Q3	$7.5K	Hold	125,000	–	–	0.01%	97
2023 Q2	$18.8K	Hold	125,000	–	–	0.01%	87
2023 Q1	$10K	Hold	125,000	–	–	﹤0.01%	156
2022 Q4	$3.75K	Hold	125,000	–	–	﹤0.01%	233
2022 Q3	$10K	Buy	+125,000	New	+$13.9K	﹤0.01%	283

Atalaya Capital Management's BIOSW Position: Q4 2023 in Review

Atalaya Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 125,000 shares — an estimated $7.5K sold.

Atalaya Capital Management first reported a position in BIOSW in Q3 2022 and held it in 5 quarters. The position peaked at $18.8K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Atalaya Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Atalaya Capital Management sold 125,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $7.5K.
Atalaya Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q3 2022 and held it in 5 quarters.
Atalaya Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $18.8K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Atalaya Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.